10 results match your criteria: "Inform Diagnostics Research Institute[Affiliation]"
RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates.
Gut
February 2024
Microbiome Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
At the end of the last century, a far-sighted 'working party' held in Sydney, Australia addressed the clinicopathological issues related to gastric inflammatory diseases. A few years later, an international conference held in Houston, Texas, USA critically updated the seminal Sydney classification. In line with these initiatives, Kyoto Global Consensus Report, flanked by the Maastricht-Florence conferences, added new clinical evidence to the gastritis clinicopathological puzzle.
View Article and Find Full Text PDFGastric cancer risk in autoimmune gastritis: evidence versus opinion.
Gut
February 2024
Medicine (111D), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
Gastric granulomas and Helicobacter pylori: An incidental relationship.
Helicobacter
June 2021
Inform Diagnostics Research Institute, Irving, TX, USA.
Aims: Studies investigating the relationship between granulomatous gastritis (GG) and Helicobacter pylori infection have been largely inconclusive. This study was designed to determine whether the analysis of a very large number of patients would provide clearer answers evaluate the association between H. pylori infection and gastric granulomas.
View Article and Find Full Text PDFAGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors.
Gastroenterology
February 2020
Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, Kansas.
AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes.
Gastroenterology
February 2020
Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, Kansas.
Clinicopathologic comparison of Rowell syndrome, erythema multiforme, and subacute cutaneous lupus erythematosus.
J Am Acad Dermatol
December 2019
Department of Dermatology, University of Florida College of Medicine, Gainesville, Florida. Electronic address:
Lichenoid granulomatous dermatitis revisited: A retrospective case series.
J Am Acad Dermatol
November 2019
Department of Dermatology, University of Florida College of Medicine, Gainesville, Florida. Electronic address:
Article Synopsis
- Lichenoid granulomatous dermatitis (LGD) is a rare skin reaction that presents challenges in establishing clinical links, characterized by both vacuolar degeneration and the formation of granulomas.
- A study at multiple institutions identified 56 cases of LGD, highlighting common clinical correlates such as drug reactions (39.3%) and lichenoid keratosis (19.6%), among others.
- Findings suggest that specific skin changes, like dermal eosinophils and psoriasiform changes, could assist in diagnosing LGD, although the study's retrospective nature limits its overall power.
Comparison of the Inflammatory Infiltrates in Tumoral Melanosis, Regressing Nevi, and Regressing Melanoma.
Am J Dermatopathol
July 2019
Department of Dermatology, University of Florida College of Medicine, Gainesville, FL.
Background: Tumoral melanosis (TM) is a histologic diagnosis characterized by abundant pigment-laden macrophages in the dermis. It is generally thought to represent a regressed melanoma, although it has also been reported after benign pigmented lesions as well. Determining the antecedent lesion in cases of TM is of clinical importance to accurately guide therapy and prognostication.
View Article and Find Full Text PDFOLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients.
Am J Gastroenterol
November 2018
Department of Medicine (DIMED), Surgical pathology & Cytopathology Unit, University of Padova-Azienda Ospedaliera di Padova, Padova, Italy. Veneto Tumor Registry, Veneto Region, Padova, Italy. Departments of Pathology and Medicine, Baylor College of Medicine, Houston, TX, USA. Inform Diagnostics Research Institute, Irving, TX, USA. Department of Oncology and Gastroenterology (DISGOG), Gastroenterology Unit, University of Padova-Azienda Ospedaliera di Padova, Padova, Italy. Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, Germany.
Objectives: Gastritis OLGA-staging ranks the risk for gastric cancer (GC) in progressive stages (0-IV). This long-term follow-up study quantifies the GC risk associated with each OLGA stage.
Methods: Consecutive patients (7436) underwent esophagogastroscopy (T-0), with mapped gastric biopsies, OLGA staging, and H.
Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.
Gastroenterology
July 2018
Eli and Edythe L. Broad Institute, Cambridge, Massachusetts; Department of Molecular Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. Electronic address:
Background & Aims: Barrett's esophagus (BE) is the greatest risk factor for esophageal adenocarcinoma (EAC), but only a small proportion of patients with BE develop cancer. Biomarkers might be able to identify patients at highest risk of progression. We investigated genomic differences in surveillance biopsies collected from patients whose BE subsequently progressed compared to patients whose disease did not progress.
View Article and Find Full Text PDF